GRAUWEIL76.30

Grauer & Weil India Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASINDOKEMJYOTIRESKANCHI
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Inventory Days (DIO)89.0095.54108.08
Receivable Days (DSO)63.5663.4453.99
Asset Turnover0.940.880.82
Cash Conversion (CFO/Net Income)1.100.920.92
CFO/EBITDA0.840.770.78
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.